In the published article, we accidentally forgot to disclose a conflict of interest. One of the corresponding authors, Hening Lin, is a founder and consultant for Sedec Therapeutics. We are sorry for this oversight and any inconvenience it may have caused. This article has not yet been cited by other publications.

In the original manuscript, the (S)-configuration was mistakenly shown for Cys26 in Figure 1C. The current version of the figure shows the proteinogenic (R)-configuration at this position. All related stereochemical configuration changes have been made in the updated supporting documentation. The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acschembio.1c00536

This article has not yet been cited by other publications.

During the course of followup studies, it was found that floxuridine MICs from the UM samples in this study were too high by a factor of 100, likely due to an error in making the working stock solution for this compound. Corrected data in Table 2 and Table 3 and for floxuridine in supplemental Table S1 are in bold. The upper section shows those agents with substantially enhanced activity in the presence